Colgate Palmolive (CL) Net Income towards Common Stockholders (2009 - 2026)

Colgate Palmolive's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $681.0 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 6.2% year-over-year to $681.0 million in Q1 2026; TTM through Mar 2026 was $2.2 billion, a 27.33% decrease from a year earlier, with the FY2025 full-year figure at $2.3 billion, down 25.84% from the prior year.
• Net Income towards Common Stockholders grew to $681.0 million in Q1 2026 per CL's latest filing, from -$5.0 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $779.0 million in Q4 2024 and bottomed at -$5.0 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is $726.0 million (2025), against an average of $612.6 million.
• Across the five-year window, Net Income towards Common Stockholders surged 1667.44% in 2023 and plunged 100.64% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $43.0 million in 2022, then jumped by 1667.44% to $760.0 million in 2023, then rose by 2.5% to $779.0 million in 2024, then plunged by 100.64% to -$5.0 million in 2025, then jumped by 13720.0% to $681.0 million in 2026.
• Per Business Quant, the three latest CL Net Income towards Common Stockholders figures stand at $681.0 million (Q1 2026), -$5.0 million (Q4 2025), and $766.0 million (Q3 2025).